Granite Point Capital Management, L.P. Bristol Myers Squibb CO Transaction History

Granite Point Capital Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 29, 2019	SELL	$44.62 - $49.34 $892,400 - $986,800	-20,000 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$45.12 - $53.8 $902,400 - $1.08 Million	20,000 New	20,000 $954,000
Q2 2018 Aug 13, 2018	SELL	$50.53 - $62.98 $1.05 Million - $1.31 Million	-20,800 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$59.92 - $68.98 $551,264 - $634,616	-9,200 Reduced 30.67%	20,800 $1.32 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $1.66 Million - $1.91 Million	30,000	30,000 $1.91 Million

2,407

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $115B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Granite Point Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Granite Point Capital Management, L.P. with notifications on news.